The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory hodgkin disease: A southwest oncology group phase II trial

Authors:
  • JUJoseph M Unger
    Joseph M Unger
  • SFStephen J Forman
    Stephen J Forman
  • AMAnne R McCall
    Anne R McCall
  • MLMichael LeBlanc
    Michael LeBlanc
  • ANAuayporn P Nademanee
    Auayporn P Nademanee
  • BBBrian J Bolwell
    Brian J Bolwell
  • RFRichard I Fisher
    Richard I Fisher

Abstract
No abstract available

This publication has 47 references indexed in Scilit: